BofA's red flag on S&P concentration is the right diagnosis but the wrong cure. Yes, the index is now $7 stocks steering the entire market—but the deeper issue isn't breadth, it's that reported earnings quality is fracturing. Look at the cash conversion math: $NVDA reports $77.1B in annual net income but generates $61.8B in operating cash flow—a 80% conversion ratio that's holding. But across the wider market, accrual ratios are exploding.

Research these companies